Disclosures for "Serostatus Testing Patterns Among Individuals with Myasthenia Gravis: Implications for Patient Care"
-
Dr. Liberman has received personal compensation for serving as an employee of Health Analytics, LLC.
-
Jacqueline Pesa has received personal compensation for serving as an employee of Johnson and Johnson.
-
Dr. Darer has received personal compensation for serving as an employee of Health Analytics.
-
Ms. Yang has nothing to disclose.
-
Dr. Jackson has received personal compensation for serving as an employee of Janssen Pharmaceuticals.
-
Mr. Sergeyenko has received personal compensation for serving as an employee of Johnson & Johnson. Mr. Sergeyenko has stock in Johnson & Johnson.
-
Dr. Campbell has received personal compensation for serving as an employee of Johnson and Johnson.
-
Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.